腺苷介导节律性光照改善16p11.2缺失雌性小鼠的社交新颖性缺陷
研究探讨40 Hz节律性视觉闪光刺激对16p11.2缺失雌性小鼠社交新颖性缺陷的作用。结果显示长期40 Hz光照改善社交新颖性缺陷,降低前额叶皮层局部场电位功率,逆转锥体神经元过度兴奋性传递而不改变放电频率和数量。机制上40 Hz光照诱发前额叶皮层腺苷释放,通过A1受体抑制过度兴奋性传递;阻断或敲低A1受体完全消除有益效应。
要点
- 16p11.2缺失雌性小鼠表现出强烈的社交新颖性缺陷,长期40 Hz光照可改善该缺陷
- 40 Hz光照降低前额叶皮层局部场电位功率,逆转锥体神经元过度兴奋性传递
- 40 Hz光照诱发的腺苷通过A1受体抑制过度兴奋性传递,阻断或敲低A1受体消除有益效应
核心结论
- 腺苷是40 Hz光照治疗改善社交新颖性缺陷的新型神经化学介质,通过减少兴奋性传递发挥作用。
- 40 Hz光照刺激值得进一步开发为非侵入性孤独症谱系障碍治疗方法。
研究设计与样本
- 研究使用16p11.2缺失雌性小鼠模型,观察长期40 Hz节律性视觉闪光刺激对社交新颖性缺陷的影响。
- 研究检测了前额叶皮层局部场电位功率、锥体神经元兴奋性传递、放电频率和驻留神经元数量。
- 研究通过药理学阻断(DPCPX)和shRNA敲低前额叶皮层A1受体验证腺苷-A1受体通路的作用。
主要发现
- 16p11.2缺失雌性小鼠表现出强烈的社交新颖性缺陷,长期40 Hz光照治疗可改善该缺陷。
- 16p11.2缺失雌性小鼠前额叶皮层局部场电位功率升高,40 Hz光照治疗有效降低该功率。
- 40 Hz光照逆转前额叶皮层锥体神经元的过度兴奋性传递,而不改变放电频率和驻留前额叶神经元数量。
- 40 Hz光照诱发前额叶皮层腺苷释放,腺苷通过A1受体抑制过度兴奋性传递并缓解社交新颖性缺陷。
- 使用特异性拮抗剂DPCPX阻断A1受体或用shRNA敲低前额叶皮层A1受体,完全消除40 Hz光照的有益效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-invasive brain stimulation therapy for autism spectrum disorder (ASD) has shown beneficial effects. Recently, we and others demonstrated that visual sensory stimulation using rhythmic 40 Hz light flicker effectively improved cognitive deficits in mouse models of Alzheimer's disease and stroke. However, whether rhythmic visual 40 Hz light flicker stimulation can ameliorate behavioral deficits in ASD remains unknown. Here, we show that 16p11.2 deletion female mice exhibit a strong social novelty deficit, which was ameliorated by treatment with a long-term 40 Hz light stimulation. The elevated power of local-field potential (LFP) in the prefrontal cortex (PFC) of 16p11.2 deletion female mice was also effectively reduced by 40 Hz light treatment. Importantly, the 40 Hz light flicker reversed the excessive excitatory neurotransmission of PFC pyramidal neurons without altering the firing rate and the number of resident PFC neurons. Mechanistically, 40 Hz light flicker evoked adenosine release in the PFC to modulate excessive excitatory neurotransmission of 16p11.2 deletion female mice. Elevated adenosine functioned through its cognate A1 receptor (A1R) to suppress excessive excitatory neurotransmission and to alleviate social novelty deficits. Indeed, either blocking the A1R using a specific antagonist DPCPX or knocking down the A1R in the PFC using a shRNA completely ablated the beneficial effects of 40 Hz light flicker. Thus, this study identified adenosine as a novel neurochemical mediator for ameliorating social novelty deficit by reducing excitatory neurotransmission during 40 Hz light flicker treatment. The 40 Hz light stimulation warrants further development as a non-invasive ASD therapeutics.
引用
- Ju J, Li X, Pan Y, et al. Adenosine mediates the amelioration of social novelty deficits during rhythmic light treatment of 16p11.2 deletion female mice. Mol Psychiatry. 2024. PMID: 38740879. doi:10.1038/s41380-024-02596-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。